About the company
RoukenBio is a biotechnology company based in Motherwell, Scotland. They specialise in immunology and cell-based assays combined with cell and tissue expression analysis. Antibody Analytics focus on understanding key scientific questions and the underlying biology to apply complex model systems tailored to specific targets and disease biology. Their mission is to support biopharmaceutical companies by providing high-quality data that helps overcome significant scientific challenges.
The company offers comprehensive in vitro pharmacology data packages to aid in regulatory submissions. This includes characterisation of antibody-based drugs, binding efficacy, potency, and non-regulated toxicology studies. With advanced tools like the 4-laser Quanteon flow cytometer, RoukenBio provides detailed immune and target cell characterisation, enabling in-depth analysis of cell function, activation, and proliferation across various immune cell assays.
KTP Aim
The aim of the KTP project with the School of Health & Life Sciences and RoukenBio
is to develop translational assays for evaluating therapeutic molecules.
KTP Associate
Athanasios Koulis is the KTP Associate on this project, which began in June 2024 and has
been working hard to navigate the early stages of the KTP project.
This KTP project will give me an opportunity to apply my academic skills to real-world business challenges. This experience will help me better understand the complexities of industry-specific problems and support me to further improve my problem-solving skills.
Athanasios Koulis, KTP Associate, RoukenBio